Affimed and NKGen Biotech Announce Initiation of Patient Recruitment in a First-in-human Phase 1/2a Trial of Innate Cell Engager AFM24 in Combination with Autologous NK Cell Product SNK01

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach